Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
CONMED Corporation(CNMD)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for CNMD
11/09/2026: CNMD (2-star) is currently NOT-A-BUY. Pass it for now.
CONMED Corporation is a medical technology company specializing in surgical and orthopedic devices for minimally invasive procedures. The company’s primary strength lies in its focused portfolio of specialized instrumentation, which has built a strong reputation among surgeons. Its growth story is centered on organic innovation and strategic acquisitions designed to expand its footprint in high-growth segments like sports medicine. Investors should be aware of risks including stiff competition from large-cap medical device firms, pricing pressures from hospital systems, and sensitivity to elective surgery volumes. This stock may suit growth-oriented investors looking for exposure to surgical technology, provided they monitor the company’s ability to defend its market share.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | The company offers moderate growth potential through specialized surgical products but faces challenges from larger competitors. |
| Momentum investor | Mixed fit | This style is conditional on the stock showing a positive upturn signal and sustained outperformance in the medical device sector. |
| Value investor | Mixed fit | Valuation often tracks the broader med-tech market, requiring careful entry points relative to earnings growth expectations. |
| Dividend investor | Mixed fit | CONMED provides modest income, but investors seeking high yields may find better options elsewhere in the broader market. |
| Low-risk investor | Weak fit | The company operates in a competitive and regulated industry, leading to potential volatility in stock price and earnings. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium / high | The stock is subject to broader healthcare sector sentiment and specific surgical volume trends. |
| Valuation risk | Medium | Market pricing of medical device stocks can fluctuate significantly based on growth expectations. |
| Competition risk (Large cap med-tech) | High | Large competitors like Stryker and Medtronic have deeper resources for R&D and market penetration. |
| Business quality | Medium | The company has strong niche franchises but lacks the sheer scale and diversification of industry giants. |
| Dividend income | Low | Dividends are not the primary return mechanism, and the yield may be modest. |
| Execution risk | Medium | Successfully integrating acquisitions and launching new technologies is critical for long-term growth. |
Price Behavior
Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.
Moderately Choppy
The stock has experienced noticeable price swings while retaining some directional structure.
Analysis of Past Performance
Type Stock | Historic Profit -57.44% | Avg. Invested days 22 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 11/09/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.53B USD | Price to earnings Ratio 21.37 | 1Y Target Price 46.83 |
Price to earnings Ratio 21.37 | 1Y Target Price 46.83 | ||
Volume (30-day avg) 414.6K shares | Beta 0.9 | 52 Weeks Range 31.44 - 54.80 | Updated Date 11/08/2026 |
52 Weeks Range 31.44 - 54.80 | Updated Date 11/08/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 2.41 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Orthopedics | Sports medicine and arthroscopy devices. | Selling tools for surgeons to fix joints and sports injuries. |
| General Surgery | Electrosurgery and endoscopy products. | Providing equipment for a wide range of minimally invasive surgeries. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2026-10-28 | When After Market | Estimate 1 | Actual 1.04 |
Profitability
Profit Margin 5.36% | Operating Margin (TTM) 9.64% |
Management Effectiveness
Return on Assets (TTM) 3.79% | Return on Equity (TTM) 7.1% |
Valuation
Trailing PE 21.37 | Forward PE 27.17 | Enterprise Value 2.30B | Price to Sales(TTM) 1.12 |
Enterprise Value 2.30B | Price to Sales(TTM) 1.12 | ||
Enterprise Value to Revenue 1.68 | Enterprise Value to EBITDA 10.74 | Shares Outstanding 29.80M | Shares Floating 29.50M |
Shares Outstanding 29.80M | Shares Floating 29.50M | ||
Percent Insiders 0.43 | Percent Institutions 115.52 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.